Portrazza

Medicinal product

(Invented) name

Portrazza

Active substance (s)

Necitumumabas

Strength

800 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FE03, Necitumumab

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2016-02-15

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 vnt.
Necitumumabas	800 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65201	79701	1079701	flakonas	N1		Receptinis	EU/1/15/1084/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2016-02-15	Registruotas